🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To test whether Parcopa, a new Orally Disintegrating Tablet of Carbidopa-Le...
Status
Completed
Location
Schwarz
Start Date
2005-06
Trial ID
NCT00139880
Treatments Being Tested
To investigate the effect of rising oral single-doses of BIA 6-512 (25 mg, ...
Status
Completed
Location
Human Pharmacology Unit (UFH)
Start Date
2004-11-03
Trial ID
NCT03091868
Treatments Being Tested
The primary objective of this study is to provide continued access to levod...
Status
Completed
Location
University of Alabama at Birmingham /ID# 49941
Start Date
2009-11-13
Trial ID
NCT00660673
To investigate the effect of three single oral doses of BIA 9-1067 (25 mg, ...
Status
Completed
Location
BIAL - Portela & Cª - Human Pharmacology Unit (UFH)
Start Date
2009-01
Trial ID
NCT02169466
Treatments Being Tested
The purpose of this study is to evaluate whether the DopaFuse System can re...
Status
Completed
Location
San Raffaele Cassino
Start Date
2021-06-16
Trial ID
NCT04778176
Treatments Being Tested
This will be a randomised, crossover, double-blind, double-dummy, active-co...
Status
Completed
Location
Clinical Research Services Turku CRST
Start Date
2016-04-08
Trial ID
NCT02764125
Treatments Being Tested
This study is designed to assess the effect of APOKYN treatment in rapid an...
Status
Completed
Location
Keck School of Medicine
Start Date
2012-12
Trial ID
NCT01770145
Treatments Being Tested
The primary objective of this study was to demonstrate the superiority of l...
Status
Completed
Location
Site Reference ID/Investigator# 45719
Start Date
2009-01
Trial ID
NCT00357994
Hormonal transition periods during the menstrual cycle may predispose women...
Status
Unknown
Location
Department of Psychiatry & Psychotherapy, University of Tübingen
Start Date
2024-05
Trial ID
NCT06365515
Treatments Being Tested
The primary purpose is to demonstrate superiority of Rotigotine over Placeb...
Status
Terminated
Location
011
Start Date
2012-01
Trial ID
NCT01536015
Treatments Being Tested